Pinned post
Update: Now published in @NatureComms, please check out our work, "Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinoma" w @srviswanathan @DrChoueiri @LabSignoretti @VanAllenLab @Cary_Weiss @DanaFarber_GU
🔗 lnkd.in/exzvuJeS
lnkd.in LinkedIn This link will take you to a page that’s not on LinkedIn 🔗 lnkd.in/exzvuJeS
Late 🧵, but excited to share the first part of my postdoc work under @srviswanathan ’s mentorship!View quoted post on X
🔗 tinyurl.com/yvbhp243
Our work focuses on translocation RCC (tRCC) — a rare & aggressive kidney cancer that remains a black box despite progress in clear-cell RCC.